Human LTBP1 ELISA Kit (2) (V2LY-0626-LY5927)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Sensitivity
0.0054 ng/mL
Detection Range
0.01-3 ng/mL
Sample Type
Serum, Plasma, cell culture supernates
Specificity
Human
Assay Type
Sandwich
Reactivity
Human
Assay Time
1.5 h
Molecule Mass
186.8 kDa
Components
  • Pre-coated ELISA plate: 12 wells * 8 detachable strips
  • Standard solution: 0.5ml x1
  • Standard diluent: 3ml x1
  • Streptavidin-HRP: 6ml x1
  • Stop solution: 6ml x1
  • Substrate solution A: 6ml x1
  • Substrate solution B: 6ml x1
  • Wash buffer concentrate (25x): 20ml x1
  • Biotinylated antibody: 1ml x1

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 2-8°C
More Infomation

Target

Full Name
latent transforming growth factor beta binding protein 1
Function
Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:2022183, PubMed:8617200, PubMed:8939931).
Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:8617200, PubMed:8939931, PubMed:15184403).
Outcompeted by LRRC32/GARP for binding to LAP regulatory chain of TGF-beta (PubMed:22278742).
Biological Process
Regulation of transforming growth factor beta activationManual Assertion Based On ExperimentIDA:UniProtKB
Sequestering of TGFbeta in extracellular matrixManual Assertion Based On ExperimentIDA:UniProtKB
Cellular Location
Secreted
Secreted, extracellular space, extracellular matrix
Involvement in disease
Cutis laxa, autosomal recessive, 2E (ARCL2E):
A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. ARCL2E patients present with cutis laxa, inguinal hernia, craniofacial dysmorphology, variable heart defects, and prominent skeletal features including craniosynostosis, short stature, brachydactyly, and syndactyly.
PTM
Contains hydroxylated asparagine residues.
Isoform Short N-terminus is blocked.
Two intrachain disulfide bonds from the TB3 domain are rearranged upon TGFB1 binding, and form interchain bonds with TGFB1 propeptide, anchoring it to the extracellular matrix.
O-glycosylated on serine residues by POGLUT2 and POGLUT3.

Li, C., Zhang, L., Bu, X., Wang, J., Li, L., & Yang, Z. (2022). Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107/ADCY1 signal. Molecular and Cellular Biochemistry, 477(4), 1127-1138.

Przyklenk, M., Georgieva, V. S., Metzen, F., Mostert, S., Kobbe, B., Callewaert, B., ... & Schiavinato, A. (2022). LTBP1 promotes fibrillin incorporation into the extracellular matrix. Matrix Biology, 110, 60-75.

Williamson, D. B., Sohn, C. J., Ito, A., & Haltiwanger, R. S. (2021). POGLUT2 and POGLUT3 O-glucosylate multiple EGF repeats in fibrillin-1,-2, and LTBP1 and promote secretion of fibrillin-1. Journal of Biological Chemistry, 297(3).

Lin, R., Li, X., Wu, S., Qian, S., Hou, H., Dong, M., ... & Zhang, M. (2021). Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/T cell lymphoma progression by inactivating the TGF-β/Smad and p38MAPK pathways. Experimental Cell Research, 407(1), 112790.

Pottie, L., Adamo, C. S., Beyens, A., Lütke, S., Tapaneeyaphan, P., De Clercq, A., ... & Callewaert, B. (2021). Bi-allelic premature truncating variants in LTBP1 cause cutis laxa syndrome. The American Journal of Human Genetics, 108(6), 1095-1114.

Zhao, Q., Zheng, K., Ma, C., Li, J., Zhuo, L., Huang, W., ... & Jiang, Y. (2020). PTPS facilitates compartmentalized LTBP1 S-nitrosylation and promotes tumor growth under hypoxia. Molecular cell, 77(1), 95-107.

Cai, R., Wang, P., Zhao, X., Lu, X., Deng, R., Wang, X., ... & Lin, J. (2020). LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation. Journal of Translational Medicine, 18(1), 1-13.

Fu, X., Zhang, P., Song, H., Wu, C., Li, S., Li, S., & Yan, C. (2020). LTBP1 plays a potential bridge between depressive disorder and glioblastoma. Journal of translational medicine, 18(1), 1-21.

Qian, H., Li, J., Zou, L., Ji, C., Li, H., Zheng, Y., ... & Zhang, Y. (2020). LTBP1-ALK: A novel fusion identified in malignant pleural effusions from a patient with advanced lung adenocarcinoma. Lung Cancer, 144, 93-97.

Mami, S., Ghaffarpour, S., Faghihzadeh, S., & Ghazanfari, T. (2019). Evaluation of the LTBP1 and Smad6 genes expression in lung tissue of Sulfur mustard-exposed individuals with long-term pulmonary complications. Iranian Journal of Allergy, Asthma and Immunology, 473-478.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human LTBP1 ELISA Kit (2)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.